Sure reads like a very disappointing press releaseI think I am reading the tea leaves correctly and that the results will be inconclusive.
We learned more on the delay in enrollment. They are having difficulty finding a homogenous group for their testing.
This is concerning because I thought that their trials were addressed for everyone with a spinal injury, instead it is limited to a more homogenous group that already has evidence of some motor mobility before entering testing.
So this is a very far cry from what I thought that it was and would apply to everyone who was paralyzed. It is only for a select group and whom are not completely paralyzed.
Thought it would have been the Holy grail but it is clearly not. Also read some concern for funding as they are now relieved that funds will last to Q3-2025.
I am definitely sitting this one out. Will wait for trial results and then see how big the market is. If you are targeting only a limited group, then market size is much smaller than boasted. Could explain the changes in personnel and also why pr firm was needed with messaging.
My personal opinion only
Good Luck,